1. Home
  2. IBO

as 04-01-2025 3:37pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

NYSE

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Founded: 2018 Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 22.1M IPO Year: 2024
Target Price: N/A AVG Volume (30 days): 8.7M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.30 EPS Growth: N/A
52 Week Low/High: $0.51 - $6.17 Next Earning Date: 05-23-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: